KCT0007770
Not yet recruiting
未知
A multicenter, open, prospective observational study to confirm the clinical efficacy and safety after drug change in patients with degenerative arthritis (spondyloarthritis, knee arthritis) treated with anti-inflammatory analgesics
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 800
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients over 20 years of age who have been diagnosed with spondyloarthritis or gonarthritis among degenerative arthritis prescribed non\-selective NSAIDs.
- •2\) Patients who have not been given Cox2\-selective NSAIDs in the treatment of degenerative arthritis within the last 2 weeks.
- •3\) Patients whose history identifies osteoarthritis with symptoms of the body and whose pain VAS test performed in Visit 2 is greater than 40 mm
- •4\) A person who voluntarily agrees to participate in this study is able to understand the information provided to him or her and can sign a written consent form at will
Exclusion Criteria
- •1\) A person diagnosed with a clinically significant mental illness and receiving medication.
- •2\) Patients who scheduled for surgery during the clinical study.
- •3\) Patients who have a history of allergies to the ingredients that make up this clinical research drug.
- •4\) A person who is deemed to have a life expectancy of less than six months due to malignant tumors or other serious health conditions affecting his/her life;
- •5\) Those who participated in another clinical study within 4 weeks before participating in the study
- •6\) Subjects who are unable to implement the clinical research process specified in the plan
- •7\) Any other person deemed inappropriate to participate in this clinical study due to the medical opinion of the researcher;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Pharmacokinetics of tacrolimus in the first days after heart and lung transplantatioHeart and lung transplantation, first days after transplantationMedDRA version: 19.0Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 100000004848Therapeutic area: Body processes [G] - Physical Phenomena [G01]EUCTR2012-001909-24-NLniversity Medical Center Utrecht30
Recruiting
Phase 4
Centralized monitoring study for safety of Traditional Chinese Medicine granulesadverse drug reactionITMCTR2000003180First Affiliated Hospital of Guang zhou University of Chinese Medicine
Recruiting
Not Applicable
Prospective, open, multicentre observational clinical study to inves- tigate safety and efficacy of cell-free Autologous Conditioned Serum (ACS) in patients with knee osteoarthritis with 3 years follow-upM17.0M17.1M17.4M17.5Primary gonarthrosis, bilateralOther primary gonarthrosisOther secondary gonarthrosis, bilateralOther secondary gonarthrosisDRKS00010478ORTHOGEN AG1,000
Completed
Not Applicable
A prospective, open label, multi-centre, observational, post-market study evaluating Juvéderm® Volift with Lidocaine for the correction of moderate to severe nasolabial folds (NLF)gezichtverouderingdermal fillersfacial agingNL-OMON37130Allergan Pharmaceuticals Ireland23
Not yet recruiting
Phase 4
STUDY OF LATEX FOLEY BALLOON CATHETER (2-WAY & 3-WAY)Health Condition 1: N394- Other specified urinary incontinenceCTRI/2022/04/042235STERIMED MEDICAL DEVICES PVT LTD